Swiss Group for Clinical Cancer Research
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sakk.ch/
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Salvage Radiotherapy SRT
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 112
- Registration Number
- NCT02945813
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire (CHRU) Jean Minjoz, Besançon, France
🇫🇷Clinique Pasteur - Centre finistérien de radiothérapie et d'oncologie, Brest, France
🇫🇷Centre de lutte contre le cancer Léon Bérard, Lyon, France
ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.
- Conditions
- Prostate Cancer MetastaticProstate Cancer
- Interventions
- Other: Placebo
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 92
- Registration Number
- NCT02933801
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre Oscar Lambret, Lille, France
🇫🇷Centre de lutte contre le cancer Léon Bérard, Lyon, France
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 25
- Registration Number
- NCT02910843
- Locations
- 🇨🇭
St. Claraspital Basel, Basel, Switzerland
🇨🇭Universitätsspital Basel, Basel, Switzerland
🇨🇭Inselspital Bern, Bern, Switzerland
Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
- First Posted Date
- 2016-08-24
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 25
- Registration Number
- NCT02877550
- Locations
- 🇨🇭
Universitaetsspital Basel, Basel, Switzerland
🇨🇭Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
🇨🇭Inselspital, Bern, Bern, Switzerland
Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer
- First Posted Date
- 2016-07-14
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 48
- Registration Number
- NCT02833766
- Locations
- 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭Kantonsspital Baden, Baden, Switzerland
🇨🇭Universitaetsspital-Basel, Basel, Switzerland
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
- Conditions
- Cancer of the ProstateProstate Cancer
- Interventions
- First Posted Date
- 2015-12-29
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 169
- Registration Number
- NCT02640534
- Locations
- 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭Universitaetsspital Basel, Basel, Switzerland
🇨🇭Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland
Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Other: standard therapyOther: standard therapy + physical activity program
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2022-11-07
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 100
- Registration Number
- NCT02597075
- Locations
- 🇦🇹
Universitätsklinikum der PMU Salzburg, Salzburg, Austria
🇦🇹Klinikum Wels-Grieskirchen GmbH, Wels, Austria
🇨🇭Tumor Zentrum Aarau, Aarau, Switzerland
Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)
- Conditions
- NSCLC Non-small Cell Lung Cancer
- Interventions
- Drug: MEDI4736 (anti-PD-L1)
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 68
- Registration Number
- NCT02572843
- Locations
- 🇨🇭
Stadtspital Triemli, Zürich, Zurich, Switzerland
🇨🇭Kantonsspital Aarau, Aarau, Switzerland
🇨🇭Kantonsspital Baden, Baden, Switzerland
Adjuvant Aspirin Treatment for Colon Cancer Patients
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 1040
- Registration Number
- NCT02467582
- Locations
- 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭Spitalzentrum Biel, Biel, Switzerland
🇨🇭Clinique de Genolier, Genolier, Switzerland
Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 190
- Registration Number
- NCT02451111
- Locations
- 🇦🇹
Akademisches Lehrkrankenhaus Feldkirch, Feldkirch, Austria
🇩🇰Aalborg Universitetshospital, Aalborg, Denmark
🇩🇰Aarhus University Hospital, Aarhus, Denmark